new
human
diseas
call
middl
east
respiratori
syndrom
mer
high
mortal
rate
emerg
middl
east
caus
viru
origin
call
human
coronaviruserasmu
medic
center
later
renam
middl
east
respiratori
syndrom
coronaviru
merscov
merscov
compar
sever
acut
respiratori
syndrom
coronaviru
sarscov
kill
almost
affect
individu
china
first
mer
patient
report
saudi
arabia
june
possibl
infect
direct
indirect
transmiss
viru
dromedari
camel
moreov
merscov
similar
isol
dromedari
camel
human
found
bat
evid
suggest
merscov
transmit
human
via
anim
human
howev
success
epidem
mer
indic
pathogen
spread
variou
part
world
predominantli
via
interhuman
transmiss
figur
humantohuman
transmiss
confirm
fact
secondarili
infect
individu
come
close
contact
primarili
infect
individu
secondarili
infect
individu
includ
famili
member
healthcar
worker
peopl
share
hospit
room
visit
patient
instanc
first
korean
patient
affect
merscov
diagnos
may
return
qatar
owe
secondari
mode
transmiss
korean
citizen
infect
merscov
short
span
time
phylogenet
analysi
also
suggest
merscov
isol
found
korean
patient
close
relat
qatar
strain
figur
coronavirus
member
coronavirida
famili
coronavirina
subfamili
found
mammal
bird
coronavirus
divid
four
genera
human
coronavirus
strain
name
discoveri
hong
kong
univers
label
oc
virus
grown
organ
cultur
sarscov
merscov
belong
genu
sarscov
merscov
genet
subgroup
lineag
b
c
respect
merscov
mainli
caus
respiratori
diseas
system
disord
gastrointestin
symptom
includ
diarrhea
queasi
also
occasion
observ
merscovinfect
individu
develop
chronic
comorbid
renal
failur
diabet
cardiac
diseas
result
high
fatal
rate
patient
histori
diabet
renal
failur
median
age
patient
report
case
year
incub
period
rang
day
median
day
physicochem
featur
merscov
list
tabl
merscov
genom
nucleotid
long
contain
open
read
frame
orf
singl
positivestrand
rna
genom
region
nucleotid
length
respect
end
compris
two
overlap
orf
translat
yield
two
larg
polyprotein
polyprotein
polyprotein
therapeut
target
merscov
p
durai
et
al
polyprotein
cleav
function
nonstructur
protein
nsp
proteolyt
activ
two
viral
proteas
call
papainlik
proteas
plpro
proteas
selfcleavag
proteolyt
process
merscov
polyprotein
requir
activ
viral
replic
addit
two
proteas
two
orf
encod
nsp
respons
viral
rnadepend
rna
polymeras
activ
rna
helicas
activ
exoribonucleas
activ
endoribonucleas
activ
methyltransferas
activ
role
essenti
involv
proofread
monitor
mutat
rate
uniqu
featur
rna
viru
gene
downstream
encod
structur
accessori
protein
spike
envelop
e
membran
nucleocapsid
n
protein
structur
protein
wherea
accessori
protein
uniqu
lineag
virus
encod
although
exact
function
accessori
protein
still
unknown
recent
studi
shown
may
import
role
evad
host
immun
respons
merscov
enter
host
protein
type
transmembran
glycoprotein
amino
acid
aa
exist
virion
surfac
trimer
subsequ
recogn
cluster
differenti
also
known
dipeptidyl
peptidas
facilit
infect
host
cell
sarscov
use
angiotensinconvert
enzym
function
receptor
merscov
sarscov
differ
cellular
select
infect
possibl
owe
select
bind
differ
receptor
transmiss
pathogenesi
merscov
merscov
infect
initi
thought
spread
zoonot
event
via
bat
phylogenet
studi
reveal
genet
connect
tylonycteri
bat
coronaviru
pipistrellu
bat
coronaviru
howev
evid
indic
merscov
origin
dromedari
camel
serolog
studi
suggest
almost
camel
africa
middl
east
seroposit
merscov
wherea
anim
sheep
goat
cow
found
neg
populationbas
seroepidemiolog
studi
suggest
seropreval
viru
sever
fold
higher
peopl
expos
camel
compar
gener
popul
moreov
antibodi
merscov
found
sampl
obtain
camel
saudi
arabia
reinforc
hypothesi
dromedari
camel
like
main
reservoir
merscov
contrast
seroreact
report
blood
sampl
obtain
blood
donor
abattoir
worker
saudi
arabia
merscov
detect
camel
egypt
local
rais
import
countri
mer
case
report
mode
transmiss
still
unknown
suspect
saliva
direct
contact
infect
camel
consumpt
milk
uncook
meat
howev
rule
exist
anoth
intermedi
host
merscov
transmiss
human
secondari
infect
may
occur
droplet
contact
viru
could
spread
either
via
air
fomit
recent
studi
infect
patient
show
common
merscov
infect
caus
acut
pneumonia
renal
failur
almost
everi
patient
develop
respiratori
problem
addit
least
onethird
studi
patient
also
report
abdomin
disord
effect
includ
inflamm
pericardium
consumpt
coagulopathi
increas
leukocyt
neutrophil
low
level
lymphocyt
platelet
red
blood
cell
moreov
hyponatremia
low
blood
level
albumin
detect
case
studi
therapeut
target
merscov
p
durai
et
al
overview
entri
replic
process
merscov
infect
host
cell
shown
figur
discuss
glycoprotein
locat
surfac
merscov
virion
interact
function
receptor
facilit
viral
entri
host
protein
consist
globular
domain
ntermin
region
domain
two
heptad
repeat
hr
transmembran
domain
domain
determin
cell
therapeut
target
merscov
p
durai
et
al
tropism
receptor
interact
wherea
membranefus
mediat
identifi
within
domain
merscov
bind
receptorbind
domain
rbd
locat
subunit
subsequ
proteas
cleavag
protein
lead
viruscel
fusion
releas
viral
genom
rna
host
cytoplasm
initi
translat
begin
continu
frameshift
therebi
produc
polyprotein
respect
compris
twothird
genom
respons
encod
nsp
wherea
remain
onethird
genom
encod
structur
protein
e
n
five
accessori
protein
virusencod
proteas
plpro
cleav
protein
differ
site
respect
result
matur
nsp
protein
involv
replic
transcript
rnadepend
rna
polymeras
helicas
encod
form
replicationtranscript
complex
complex
assembl
perinuclear
region
associ
doublemembran
vesicl
deriv
endoplasm
reticulum
er
confirm
electron
tomographi
threedimension
reconstruct
imag
sarscovinfect
vero
cell
doublemembran
vesicl
separ
vesicl
instead
part
reticulovesicular
system
alter
er
membran
genom
rna
contain
adenyl
uridylaterich
sequenc
call
transcript
regul
sequenc
nucleotid
long
sequenc
divid
genom
rna
differ
bodi
element
variou
length
transcript
regul
sequenc
either
recogn
replicationtranscript
complex
gener
discontinu
short
negativestrand
rna
subgenom
length
transcript
accessori
structur
protein
continu
fulllength
minusstrand
templat
rna
genom
length
replic
newli
synthes
genom
rna
encapsid
n
protein
cytoplasm
transport
ergolgi
intermedi
compart
assembl
protein
e
insert
membran
rough
er
subsequ
transport
ergolgi
intermedi
compart
interact
n
protein
assembl
particl
bud
vesicl
transport
cell
surfac
releas
matur
golgi
bodi
life
cycl
rna
virus
interferon
ifn
crucial
role
antivir
defens
activ
doublestrand
rna
dsrna
gener
viral
replic
pattern
recognit
receptor
includ
tolllik
receptor
tlr
retino
acid
induc
genei
rigi
like
receptor
rigi
melanoma
differentiationassoci
protein
essenti
role
innat
immun
among
tlr
specif
recogn
dsrna
ecto
domain
wherea
rigi
also
recogn
dsrna
helicas
domain
sens
dsrna
activ
immun
respons
induc
ifn
cytokin
block
viral
replic
evad
cellular
immun
respons
merscov
protein
bind
dsrna
block
induct
type
ifn
therapeut
target
spike
protein
mention
earlier
rbd
locat
subunit
bind
initi
infect
motif
subunit
facilit
membran
fusion
result
releas
viral
genet
materi
host
cell
cytoplasm
base
crystallograph
studi
rbd
merscov
subunit
rang
residu
divid
core
extern
subdomain
receptorbind
motif
rbd
locat
extern
subdomain
core
subdomain
contain
fivestrand
antiparallel
center
six
connect
helic
two
small
collect
make
globular
fold
three
disulfid
bond
balanc
core
domain
structur
intern
region
rbd
end
locat
close
one
anoth
extern
subdomain
merscov
rbd
compris
one
small
three
larg
strand
organ
antiparallel
manner
attach
rbd
core
interven
loop
attach
core
subdomain
like
clamp
upper
lower
posit
two
small
helic
join
loop
present
inner
side
sheet
fourth
disulfid
bond
form
residu
connect
mutat
studi
confirm
residu
rbd
requir
receptor
bind
thu
viral
entri
mutat
residu
significantli
inhibit
interact
rbd
three
helic
center
three
chain
adjac
core
side
groov
facilit
releas
viral
particl
cytoplasm
peptid
bind
domain
block
merscov
proteininduc
membran
fusion
report
moreov
effect
inhibitor
target
rbd
could
use
control
merscov
infect
recent
review
xia
et
al
two
antibodi
target
rbd
protein
prevent
bind
develop
found
potenti
inhibitor
merscov
two
antibodi
test
mous
model
develop
substitut
mous
orf
human
orf
assur
normal
physiolog
express
previous
develop
anim
model
effect
express
type
cell
result
nonphysiolog
express
recent
vivo
studi
modifi
vaccinia
viru
ankara
stabli
express
merscov
protein
exhibit
less
merscov
replic
moreov
vaccin
mous
infect
merscov
transduc
prove
efficaci
host
receptor
mainli
express
epitheli
cell
control
activ
hormon
chemokin
crystallograph
studi
reveal
receptor
domain
domain
eight
blade
merscov
rbd
bind
small
molecul
peptid
prevent
bind
rbd
potenti
merscov
entri
inhibitor
identifi
adenosin
deaminas
bind
protein
act
competit
inhibitor
merscov
protein
polyclon
antibodi
also
shown
inhibitori
effect
merscov
infect
vitro
human
monoclon
antibodi
mab
also
report
inhibit
merscov
infect
recent
studi
murin
model
develop
transduc
mous
nonrepl
adenoviru
express
transduc
mous
develop
pneumonia
infect
merscov
subunit
vaccin
venezuelan
equin
enceph
replicon
particl
express
merscov
protein
antivir
drug
polyi
c
evalu
infect
mous
merscov
subunit
vaccin
found
effect
viru
mous
model
develop
period
week
howev
transduct
system
regul
express
low
level
limit
express
lung
process
viral
polyprotein
necessari
discharg
matur
protein
guid
replic
transcript
merscov
genom
achiev
two
viral
proteas
plpro
locat
respect
proteas
cleav
sever
locat
initi
proteas
releas
immatur
form
autoproteolyt
process
addit
role
mention
merscov
plpro
also
affect
ubiquitin
ifnstimul
gene
isgyl
probabl
block
host
antivir
respons
merscov
plpro
abl
deubiquitin
therebi
inhibit
synthesi
merscov
plpro
domain
span
residu
protein
similar
plpro
coronavirus
residu
merscov
plpro
coordin
catalysi
crystal
structur
merscov
plpro
bound
ubiquitin
reveal
interact
amino
acid
activ
site
plpro
addit
eight
differ
plpro
residu
mutat
either
individu
combin
verifi
requir
bind
ubiquitin
merscov
plpro
particular
mutat
arg
major
effect
deubiquitin
process
polyprotein
essenti
viral
matur
merscov
plpro
consid
promis
antivir
target
recent
studi
dual
noncoval
inhibitor
merscov
plpro
sarscov
plpro
identifi
highthroughput
screen
compound
current
avail
crystal
structur
result
mutat
studi
merscov
plpro
aid
develop
new
inhibitor
essenti
part
polyprotein
usual
present
monom
howev
upon
substrat
bind
dimer
format
observ
monom
two
domain
ii
along
ctermin
domain
import
drug
target
proteas
activ
crucial
viral
surviv
replic
recent
studi
inhibitor
identifi
two
cocrystal
enzym
one
two
peptidomimet
compound
contain
michael
acceptor
group
noncoval
properti
irrevers
compound
michael
acceptor
group
prevent
dimer
timedepend
manner
similarli
noncoval
peptidomimet
compound
inhibit
activ
high
concentr
although
limit
number
inhibitor
avail
current
knowledg
key
conserv
nonconserv
residu
valuabl
knowledg
interact
residu
cocrystal
compound
enabl
develop
inhibitor
rel
effect
recent
studi
found
chloropyridin
ester
inhibitor
sarscov
also
inhibit
activ
merscov
reduc
achiev
transfect
cell
plasmid
evalu
proteas
activ
luciferasebas
biosensor
assay
accessori
protein
coronaviru
specif
group
gene
respons
encod
accessori
protein
accessori
protein
particip
structur
merscov
particl
essenti
role
viral
replic
evas
host
immun
respons
difficult
studi
low
express
level
well
low
molecular
weight
addit
conserv
coronaviru
subfamili
although
accessori
protein
target
antivir
therapeut
biolog
function
protein
still
well
understood
merscov
five
accessori
protein
encod
variou
orf
first
four
accessori
protein
locat
structur
protein
e
wherea
resid
downstream
n
protein
protein
contain
aa
respect
ifn
secret
virusinfect
host
cell
provid
protect
shield
expos
cell
type
ifn
inflammatori
cytokin
produc
result
recognit
pathogenassoci
molecular
pattern
tlr
rigilik
helicas
protein
demonstr
involv
inhibit
ifn
product
particular
strongli
affect
viral
pathogenesi
protein
one
accessori
protein
block
ifn
induct
work
strong
inhibitor
type
ifn
inhibit
dsrna
recognit
cellular
rigi
rigilik
helicas
rigi
recogn
dsrna
cytoplasm
time
viral
replic
initi
ifn
induct
rigilik
helicas
compris
two
domain
rnabind
domain
caspas
activ
recruit
domain
dsrna
bind
rnabind
domain
induc
conform
chang
rigi
therebi
expos
caspas
activ
recruit
domain
caspas
activ
recruit
domain
initi
downstream
signal
detect
mitochondri
antivir
signal
adaptor
protein
present
mitochondri
surfac
downstream
signal
involv
activ
phosphoryl
form
homodim
dimer
enter
nucleu
initi
transcript
case
infect
merscov
infect
cell
abl
produc
ifn
interfer
protein
hinder
bind
dsrna
rigilik
helicas
protein
aa
long
contain
rnabind
domain
compris
aa
rnabind
domain
bind
dsrna
allow
bind
rnabind
domain
rigi
therebi
inhibit
antivir
signal
pathway
thu
viru
block
innat
immun
respons
continu
infect
cell
two
key
residu
involv
bind
rna
rnabind
domain
inhibit
protein
allow
host
cell
initi
immun
respons
viru
refer
therapeut
find
sarscov
possibl
find
merscov
subunit
vaccin
review
zhang
et
al
mycophenol
acid
cyclosporin
effect
inhibit
merscov
replic
ribavirin
previous
use
sarscov
also
found
control
merscov
moreov
effici
ribavirin
merscov
increas
cotreat
collect
dual
inhibitor
merscov
sarscov
select
list
compound
vitro
studi
use
merscov
jordan
strain
addit
found
inhibit
merscov
replic
test
use
strain
similar
studi
four
food
drug
administrationapprov
drug
loperamid
chlorpromazin
lopinavir
chloroquin
identifi
inhibit
merscov
replic
micromolar
concentr
addit
small
molecul
inhibit
membranebound
merscov
replic
identifi
screen
compound
merscov
e
protein
involv
viral
assembl
bud
intracellular
traffick
target
antivir
activ
vitro
studi
major
role
confirm
initi
antivir
find
thu
sever
cell
line
suitabl
merscov
transfect
report
inform
summar
tabl
conclud
remark
merscov
persist
lifethreaten
diseas
coronaviru
rapidli
evolv
mer
emerg
global
pandem
despit
research
effort
undertaken
far
exact
intermedi
host
merscov
spatial
distribut
still
well
known
addit
data
origin
evolut
merscov
lack
global
health
concern
viru
increas
effect
therapeut
target
merscov
p
durai
et
al
antimerscov
drug
vaccin
yet
develop
approv
protein
involv
merscov
entri
replic
attract
target
develop
antivir
therapeut
avail
crystal
structur
viral
structur
nonstructur
accessori
protein
understand
bind
mechan
report
inhibitor
may
help
develop
effect
antimerscov
drug
develop
suitabl
murin
model
avail
drugtest
techniqu
sped
identif
new
drug
confirm
antivir
efficaci
compani
eager
develop
effect
vaccin
drug
consid
lack
commerci
benefit
sale
howev
avoid
anoth
unexpect
global
pandem
futur
necessari
develop
effect
therapi
initi
taken
profitpursu
compani
must
carri
forward
govern
develop
countri
philanthrop
scientist
